Abstract |
The present experiments were performed to investigate the effects of the selective mu opioid receptor antagonist, beta-funaltrexamine ( beta-FNA), on the physical dependence liability of butorphanol (a mixed agonist/ antagonist opioid analgesic). Butorphanol (26 nmol/microliter/h) was continuously infused via osmotic minipumps into the lateral cerebral ventricle of male Sprague-Dawley rats for 72 h. beta-FNA (12, 24, and 48 nmol/5 microliter/rat) was administered ICV 3 h prior to and 48 h after initiation of the butorphanol infusion. Treatment with beta-FNA significantly diminished naloxone-induced escape behavior, hypothermia, and loss of body weight in a dose-dependent manner, while naloxone-induced teeth-chattering, forepaw tremors, and urination were also reduced, but in a dose-independent manner. These results suggest that the mu opioid receptor is partially involved in the development of physical dependence upon butorphanol.
|
Authors | K W Oh, M Makimura, S P Jaw, B Hoskins, I K Ho |
Journal | Pharmacology, biochemistry, and behavior
(Pharmacol Biochem Behav)
Vol. 42
Issue 1
Pg. 29-34
(May 1992)
ISSN: 0091-3057 [Print] United States |
PMID | 1528943
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Narcotic Antagonists
- Naloxone
- Naltrexone
- beta-funaltrexamine
- Butorphanol
|
Topics |
- Animals
- Behavior, Animal
(drug effects)
- Body Temperature
(drug effects)
- Body Weight
(drug effects)
- Butorphanol
(administration & dosage)
- Dose-Response Relationship, Drug
- Injections, Intraventricular
- Male
- Naloxone
(pharmacology)
- Naltrexone
(analogs & derivatives, pharmacology)
- Narcotic Antagonists
(pharmacology)
- Rats
- Rats, Inbred Strains
- Reinforcement Schedule
- Substance Withdrawal Syndrome
(psychology)
- Substance-Related Disorders
(prevention & control, psychology)
|